LBA-002 - A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)
Autor: | Bekaii-Saab, T., Starodub, A., El-Rayes, B., O’Neil, B., Shahda, S., Ciombor, K., Noonan, A., Hanna, W., Sehdev, A., Shaib, W., Mikhail, S., Neki, A., Oh, C., Li, Y.Z., Li, W., Borodyansky, L., Li, C.J. |
---|---|
Zdroj: | In Annals of Oncology June 2017 28 Supplement 3:iii150-iii150 |
Databáze: | ScienceDirect |
Externí odkaz: |